FDA Clearance Tracker · P040038-S043
XACT Carotid Stent System
Last checked: Nov 20, 2026Latest source record: Feb 7, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Feb 7, 2024
Approved
Time to decision
225 days
Received Jun 27, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P040038-S043
- Device name
- XACT Carotid Stent System
- Applicant
- Abbott Vascular, Inc.
- Applicant location
- Santa Clara, CA
- Received
- Jun 27, 2023
- Decided
- Feb 7, 2024
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P040038
Device type
- Device type
- Stent, carotid (NIM)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
the expansion of the indications to include use of the XACT Carotid Stent System in conjunction with the ENROUTE NPS device during Transcarotid Artery Revascularization (TCAR) procedures
Source documents
Other decisions for Abbott Vascular, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Perclose ProStyle Suture-Mediated Closure and Repair System, Perclose ProGlide Suture-Mediated Closure SystemPMA supplement
P960043-S118 · Decided Jun 2, 2023 · 256 days after receipt · Panel Track
Device type: Device, hemostasis, vascular (MGB) · Cardiology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.